Attitudes toward harm reduction among substance use treatment professionals in Philadelphia

References

• Aletraris, L., Edmond, M. B., Paino, M., Fields, D., & Roman, P. M. (2016). Counselor training and attitudes toward pharmacotherapies for opioid use disorder. Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse, 37(1), 47–53. https://doi.org/10.1080/08897077.2015.1062457
   PubMedGoogle Scholar
• Baker, L. S., Smith, W., Gulley, T., & Tomann, M. M. (2020, April). Community perceptions of comprehensive harm reduction programs and stigma towards people who inject drugs in rural virginia. Journal of Community Health, 45(2), 239–244. https://doi.org/10.1007/s10900-019-00732-8
   PubMed Web of Science ®Google Scholar
• Bigg, D. (2001, Jan-Mar). Substance use management: A harm reduction-principled approach to assisting the relief of drug-related problems. Journal of Psychoactive Drugs, 33(1), 33–38. https://doi.org/10.1080/02791072.2001.10400466
   PubMed Web of Science ®Google Scholar
• Davis, A. K., & Rosenberg, H. (2013). Acceptance of non-abstinence goals by addiction professionals in the United States. Psychology of Addictive Behaviors, 27(4), 1102–1109. https://doi.org/10.1037/a0030563
   PubMed Web of Science ®Google Scholar
• Estreet, A., Archibald, P., Tirmazi, M. T., Goodman, S., & Cudjoe, T. (2017). Exploring social work student education: The effect of a harm reduction curriculum on student knowledge and attitudes regarding opioid use disorders. Taylor & Francis. https://doi.org/10.1080/08897077.2017.1341447
   Google Scholar
• Forman, R., Bovasso, G., & Woody, G. (2001, August). Staff beliefs about addiction treatment. Journal of Substance Abuse Treatment, 21(1), 1–9. https://doi.org/10.1016/S0740-5472(01)00173-8
   PubMed Web of Science ®Google Scholar
• Gibson, D. R., Flynn, N. M., & Perales, D. (2001). Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS, 15(11), 1329–1341. https://doi.org/10.1097/00002030-200107270-00002
   PubMed Web of Science ®Google Scholar
• Goddard, P. (2003, June). Changing attitudes towards harm reduction among treatment professionals: A report from the American Midwest. International Journal of Drug Policy, 14(3), 257–260. https://doi.org/10.1016/S0955-3959(03)00075-6
   Google Scholar
• Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009, April). Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381. h ttps://d oi.o rg/1 0.1 016/j.jbi.2008.08.010
   PubMed Web of Science ®Google Scholar
• Hawk, M., Coulter, R. W. S., Egan, J. E., Fisk, S., Friedman, M. R., Tula, M., & Kinsky, S. (2017, 2019, November 5). Harm reduction principles for healthcare settings. Harm Reduction Journal, 14(1), 70. h ttps://d oi.o rg/h ttp://d x.d oi.org/1 0.1186/s12954-017-0196-4
   PubMedGoogle Scholar
• IBM. (2016). 2016 IBM annual report. https://www.ibm.com/investor/att/pdf/IBM_Annual_Report_2016.pdf
   Google Scholar
• Kennedy, M. C., Karamouzian, M., & Kerr, T. (2017, October). Public health and public order outcomes associated with supervised drug consumption facilities: A systematic review. Current HIV/AIDS Reports, 14(5), 161–183. https://doi.org/10.1007/s11904-017-0363-y
   PubMed Web of Science ®Google Scholar
• Klein, A. A., & Seppala, M. D. (2019, September). Medication-assisted treatment for opioid use disorder within a 12-step based treatment center: Feasibility and initial results. Journal of Substance Abuse Treatment, 104, 51–63. https://doi.org/10.1016/j.jsat.2019.06.009
   PubMed Web of Science ®Google Scholar
• Knudsen, H. K., Ducharme, L. J., Roman, P. M., & Link, T. (2005). Buprenorphine diffusion: The attitudes of substance abuse treatment counselors. Journal of Substance Abuse Treatment, 29(2), 95–106. https://doi.org/10.1016/j.jsat.2005.05.002
   PubMed Web of Science ®Google Scholar
• Kyser, N. M. (2010). Counselor attitudes toward the harm reduction approach in substance abuse treatment old dominion university. ODU Digital Commons. https://digitalcommons.odu.edu/cgi/viewcontent.cgi?article=1069&context=chs_etds
   Google Scholar
• Lange, B. C. L., & Bach-Mortensen, A. M. (2019). 2019/04/01/). A systematic review of stakeholder perceptions of supervised injection facilities. Drug and Alcohol Dependence, 197, 299–314. https://doi.org/10.1016/j.drugalcdep.2019.02.006
   PubMed Web of Science ®Google Scholar
• Lauritsen, K. J. (2017). Do psychological characteristics of addiction treatment professionals predict acceptance of harm reduction interventions? Bowling Green State University and OhioLINK. http://rave.ohiolink.edu/etdc/view?acc_num=bgsu1497572679919639
   Google Scholar
• McGinty, E. E., Barry, C. L., Stone, E. M., Niederdeppe, J., Kennedy-Hendricks, A., Linden, S., & Sherman, S. G. (2018, June 1). Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. Preventive Medicine, 111, 73–77. https://doi.org/10.1016/j.ypmed.2018.02.026
   PubMed Web of Science ®Google Scholar
• NIDA. (2017). Naloxone for opioid overdose: Life-saving science. https://www.drugabuse.gov/publications/naloxone-opioid-overdose-life-saving-science
   Google Scholar
• Nielson, E. M. (2016). Substance abuse counselors’ recovery status and self schemas: Preliminary implications for empirically supported treatment implementation. Journal of Drug and Alcohol Research, 5, 1–7. https://doi.org/10.4303/jdar/235982
   Google Scholar
• North America Syringe Exchange Network. (2020). SEP Locations [Webpage]. [SEP Locations in the United States]. Internet, Dave Purchase Initiative. https://www.nasen.org/map/
   Google Scholar
• Pennsylvania, C. O. (2020). Opioid/Heroin Reversal (Naloxone). The Commonwealth of Pennsylvania. https://www.ddap.pa.gov/overdose/pages/naloxone_reversal.aspx#
   Google Scholar
• Philadelphia, T. C. O. (2020, July 7). Opioid Overdoses. The Commonwealth of Pennsylvania. https://hip.phila.gov/EmergentHealthTopics/Opioids
   Google Scholar
• Ritter, A., & Cameron, J. (2006, November). A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug and Alcohol Review, 25(6), 611–624. https://doi.org/10.1080/09595230600944529
   PubMed Web of Science ®Google Scholar
• Rogers, S. J., & Ruefli, T. (2004, June). Does harm reduction programming make a difference in the lives of highly marginalized, at-risk drug users? Harm Reduction Journal, 1(1), 7. https://doi.org/10.1186/1477-7517-1-7
   PubMedGoogle Scholar
• Rosenberg, H., & Phillips, K. T. (2003). Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies. Psychology of Addictive Behaviors, 17(3), 203–210. https://doi.org/10.1037/0893-164X.17.3.203
   PubMed Web of Science ®Google Scholar
• Roth, A. M., Kral, A. H., Mitchell, A., Mukherjee, R., Davidson, P., & Lankenau, S. E. (2019, June). Overdose Prevention Site Acceptability among Residents and Businesses Surrounding a Proposed Site in Philadelphia, USA. Journal of Urban Health, 96(3), 341–352. https://doi.org/10.1007/s11524-019-00364-2
   PubMed Web of Science ®Google Scholar
• Rouhani, S., White, R. H., Park, J. N., & Sherman, S. G. (2020, July 1). High willingness to use overdose prevention sites among female sex workers in Baltimore, Maryland. Drug and Alcohol Dependence, 212, 108042. https://doi.org/10.1016/j.drugalcdep.2020.108042
   PubMed Web of Science ®Google Scholar
• Vakharia, S. P., & Little, J. (2017, Marrch, 2018, October 6). Starting Where the Client Is: Harm Reduction Guidelines for Clinical Social Work Practice. Clinical Social Work Journal, 45(1), 65–76. h ttps://d oi.org/h ttp://d x.doi.o rg/1 0.1007/s10615-016-0584-3
   Web of Science ®Google Scholar
• Whelan, A. (2020). After surprise announcement - and cancellation - of Philly’s supervised injection site, advocates haven’t given up. The Philadelphia Inquirer. https://www.inquirer.com/news/safehouse-injection-site-philadelphia-20200229.html
   Google Scholar
• Winograd, R. P., Werner, K. B., Green, L., Phillips, S., Armbruster, J., & Paul, R. (2020). Concerns that an opioid antidote could “make things worse”: Profiles of risk compensation beliefs using the Naloxone-Related Risk Compensation Beliefs (NaRRC-B) scale. Substance Abuse, 41(2), 245–251. https://doi.org/10.1080/08897077.2019.1616348
   PubMed Web of Science ®Google Scholar
• Wood, E., Tyndall, M. W., Lai, C., Montaner, J. S. G., & Kerr, T. (2006, May). Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Substance Abuse Treatment, Prevention, and Policy, 1(1), 13. https://doi.org/10.1186/1747-597X-1-13
   PubMedGoogle Scholar